Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

ProQR Therapeutics has entered a collaboration with Ginkgo Bioworks to [...]

DeepCyte, a techbio company developing AI-driven toxicology tools for drug [...]

Scaling production of adeno-associated virus vectors remains a key barrier [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

BullFrog AI Holdings has entered a commercial agreement with a [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]